Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Postgraduate Medicine|September 24, 1999
Chronic myelogenous leukemia. Curable with early diagnosis and treatmentJ M Hill, K R MeehanGene Therapy|January 7, 2011
Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cellsA Barber, K R Meehan, C L SentmanAnnals of Internal Medicine|March 1, 1992
Prudent strategies for elective red blood cell transfusionH G Welch, K R Meehan, L T GoodnoughJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Access to bone marrow transplantation for leukemia and lymphoma: the role of sociodemographic factorsJ M Mitchell, K R Meehan, J Kong, et al.Cancer|January 28, 1999
Survival after autologous hematopoietic stem cell transplantation for patients with inflammatory breast carcinomaB Arun, R Slack, E Gehan, et al.Bone Marrow Transplantation|May 1, 1997
Suppression of progenitor cell growth by vancomycin following autologous stem cell transplantationK R Meehan, U N Verma, F Esteva-Lorenzo, et al.Journal of Hematotherapy|April 7, 1999
Differential effects of IL-2 incubation on hematopoietic potential of autologous bone marrow and mobilized PBSC from patients with hematologic malignanciesE M Areman, P L Rhodes, A Mazumder, et al.Cancer Metastasis Reviews|November 1, 1992
Clinical trials with anticoagulant and antiplatelet therapiesL R Zacharski, K R Meehan, S M Algarra, et al.American Journal of Hematology|June 1, 1995
Pretreatment fibrinogen levels are associated with response to chemotherapy in patients with small cell carcinoma of the lung: Department of Veterans Affairs Cooperative Study 188K R Meehan, L R Zacharski, T E Moritz, et al.Cancer|September 18, 1998
Idiopathic giant cell myocarditis after autologous hematopoietic stem cell transplantation and interleukin-2 immunotherapy: a case reportC I Truica, C H Hansen, D F Garvin, et al.Pageof 4